3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
13
Motor Activity
12
Fatigue
6
Lymphedema
4
Depression
4
Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Head and Neck Neoplasms
3
Breast Cancer Lymphedema
3
Anxiety Disorders
3
Respiratory Aspiration
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Hypoventilation
2
Ventricular Dysfunction, Left
1
Uterine Cervical Neoplasms
1
Trismus
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumor Cancer
1
Sarcoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Pain
1
Osteosclerosis
1
Osteoarthritis, Knee
1
Interventions
Gemcitabine
7
Doxorubicin
4
Cyclophosphamide
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
Docetaxel
3
Cisplatin
3
regorafenib
2
Vincristine
2
Tranexamic Acid
2
Sunitinib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
Radiation
2
Proton Therapy
2
Nivolumab
2
Methotrexate
2
Methods
2
Interviews as Topic
2
Indocyanine Green
2
Everolimus
2
Curettage
2
Ascorbic Acid
2
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
2
tocilizumab
1
samarium Sm-153 lexidronam
1
poly ICLC
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Bone Neoplasms
×
Exercise Therapy
×
Clear all
NCT04963517
2024-12-06
proGAIT
Universität Duisburg-Essen
Phase 2/3
Completed
11 enrolled